Oakwood Medical Investors IV (QP) LLC of St. Louis raised $2.9 million from 14 accredited investors through a private placement of LLC member interests. This brings the total amount raised to $29.2 million from 79 accredited investors. The fund, which has a target of $50 million, plans to invest in early to mid-stage development companies in pharmaceutical, medical products and biotechnology industries.?A.G. Edwards & Sons Inc., Edward D. Jones & Co. LP and Stifel, Nicolaus & Co. Inc. assisted with fund-raising.
Siguler Guff Distressed Opportunities Fund LLC of New York raised $422.3 million from 87 accredited investors through a private placement of LLC interests. The private equity fund plans to invest in distressed investment partnerships.
Stratos BioFund LP of Seattle has filed to raise $80 million through a private offering of partnership interests. The technology development fund plans to invest in biotechnology, medical device and healthcare companies.
HCM Venture Fund of British Virgin Islands has filed to raise $500 million through a private offering of common stock. At the time of its SEC filing, the fund had already raised $992,330 from three accredited investors.